25 | Poly(ADP-ribose) Polymerase InhibitorsIBA
11/2022
-
03/2005 |
20 | DNA (Deoxyribonucleic Acid)IBA
01/2023
-
01/2004 |
13 | Biomarkers (Surrogate Marker)IBA
01/2023
-
10/2013 |
12 | rucaparibIBA
11/2022
-
02/2009 |
11 | Temozolomide (Temodar)FDA LinkGeneric
09/2017
-
07/2003 |
9 | Phosphotransferases (Kinase)IBA
01/2022
-
12/2004 |
9 | Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
04/2020
-
04/2010 |
4 | PlatinumIBA
03/2021
-
08/2010 |
4 | lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA
02/2016
-
08/2012 |
4 | Proteins (Proteins, Gene)FDA Link
01/2016
-
05/2005 |
4 | Doxorubicin (Adriamycin)FDA LinkGeneric
01/2014
-
09/2010 |
4 | Poly (ADP-Ribose) Polymerase-1IBA
06/2011
-
05/2005 |
4 | EnzymesIBA
09/2010
-
07/2002 |
3 | 3- amino- 6- (4- (methylsulfonyl)phenyl)- N- phenylpyrazine- 2- carboxamideIBA
01/2022
-
03/2015 |
3 | A-Form DNA (A-DNA)IBA
04/2020
-
04/2005 |
3 | 8- dibenzothiophen- 4- yl- 2- morpholin- 4- yl- chromen- 4- oneIBA
01/2014
-
05/2006 |
3 | 1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
01/2014
-
08/2010 |
3 | PoisonsIBA
06/2013
-
01/2004 |
3 | Etoposide (VP 16)FDA LinkGeneric
06/2013
-
05/2006 |
3 | 1- (4- dimethylaminomethylphenyl)- 8,9- dihydro- 7H- 2,7,9a- benzo(cd)azulen- 6- oneIBA
10/2009
-
01/2004 |
3 | Topotecan (Hycamtin)FDA LinkGeneric
02/2009
-
07/2003 |
2 | talazoparibIBA
11/2022
-
01/2017 |
2 | olaparibIBA
11/2022
-
01/2019 |
2 | dactolisibIBA
01/2019
-
01/2016 |
2 | Small Interfering RNA (siRNA)IBA
03/2018
-
12/2008 |
2 | V158411IBA
02/2016
-
01/2016 |
2 | Serine (L-Serine)FDA Link
02/2016
-
03/2015 |
2 | Type I DNA Topoisomerases (Topoisomerase I)IBA
06/2013
-
01/2004 |
2 | CamptothecinIBA
06/2013
-
12/2005 |
2 | ProdrugsIBA
09/2011
-
07/2002 |
2 | Cisplatin (Platino)FDA LinkGeneric
08/2010
-
01/2005 |
2 | Cytotoxins (Cytolysins)IBA
07/2003
-
11/2002 |
1 | niraparibIBA
11/2022 |
1 | pamiparibIBA
11/2022 |
1 | Discoidin Domain ReceptorsIBA
04/2020 |
1 | Cyclin EIBA
01/2020 |
1 | Glutamine (L-Glutamine)FDA Link
01/2019 |
1 | Imatinib Mesylate (Gleevec)FDA Link
01/2019 |
1 | VS-5584IBA
01/2019 |
1 | Glucose (Dextrose)FDA LinkGeneric
01/2019 |
1 | Phosphoglycerate Dehydrogenase (Dehydrogenase, Phosphoglycerate)IBA
03/2018 |
1 | Keratins (Keratin)IBA
01/2018 |
1 | berzosertibIBA
01/2018 |
1 | GemcitabineFDA Link
01/2018 |
1 | Ribonucleotide Reductases (Ribonucleotide Reductase)IBA
01/2018 |
1 | VimentinIBA
01/2018 |
1 | NucleosidesIBA
01/2018 |
1 | Protein Kinases (Protein Kinase)IBA
01/2018 |
1 | Checkpoint Kinase 1IBA
04/2017 |
1 | Cell ExtractsIBA
01/2017 |
1 | Adenosine Diphosphate (ADP)IBA
05/2016 |
1 | Adenosine Diphosphate Ribose (ADP-Ribose)IBA
05/2016 |
1 | PTEN Phosphohydrolase (PTEN Phosphatase)IBA
02/2016 |
1 | MTOR InhibitorsIBA
01/2016 |
1 | (5- (2,4- bis((3S)- 3- methylmorpholin- 4- yl)pyrido(2,3- d)pyrimidin- 7- yl)- 2- methoxyphenyl)methanolIBA
01/2016 |
1 | Sirolimus (Rapamycin)FDA Link
01/2016 |
1 | Messenger RNA (mRNA)IBA
03/2015 |
1 | EWS-FLI fusion proteinIBA
07/2014 |
1 | Oncogene Proteins (Oncogene Protein)IBA
07/2014 |
1 | Topoisomerase InhibitorsIBA
12/2013 |
1 | KU59403IBA
06/2013 |
1 | Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA
08/2012 |
1 | 2- (4- ethylpiperazin- 1- yl)- N- (4- (2- morpholino- 4- oxo- 4H- chromen- 8- yl)dibenzo(b,d)thiophen- 1- yl)acetamideIBA
08/2012 |
1 | DNA Repair EnzymesIBA
12/2011 |
1 | Cyclin-Dependent Kinase 2IBA
09/2011 |
1 | NU6102IBA
09/2011 |
1 | Carboplatin (JM8)FDA LinkGeneric
02/2011 |
1 | Hormones (Hormone)IBA
01/2011 |
1 | Thioguanine (Tioguanine)FDA Link
08/2010 |
1 | Member 1 Subfamily B ATP Binding Cassette TransporterIBA
08/2010 |
1 | AlbuminsIBA
10/2009 |
1 | Niacinamide (Nicotinamide)FDA LinkGeneric
10/2009 |